0 HTTP/1.1 404 Not Found Server: cloudflare-nginx Date: Mon, 10 Mar 2014 21:38:49 GMT Content-Type: text/html; charset=UTF-8 Transfer-Encoding: chunked Connection: keep-alive X-Powered-By: PHP/5.3.18 Vary: Cookie X-Pingback: http://www.rcrwireless.com/channel/xmlrpc.php Expires: Wed, 11 Jan 1984 05:00:00 GMT Cache-Control: no-cache, must-revalidate, max-age=0 Pragma: no-cache CF-BCK-Digest: {"bck_type":"BCK_NC","up_stat":"404","host_stat":"404"} 3ad (ACAD) Acadia Pharmaceuticals Gets Pimavanserin Back | Page not found - Global Posts

404 | Page Not Found!

Sorry, but the page you were looking for is not here.

Subscribe to RCR eNewsletters

Industry Partner Events

9/15-18: CCA Annual Convention  b50 Las Vegas, NV
9/16: Telecom Analytics at CCA Las Vegas, NV

10/7-10: 2013 Wireless Infrastructure Show Hollywood, FL
10/18: Texas Wireless Summit Austin, TX

10/21-24: Futurecom 2013 Rio de Janeiro, Brazil



0
October 28, 2010 at 16:32 PM EDT
(ACAD) Acadia Pharmaceuticals Gets Pimavanserin Back
This morning, Acadia Pharmaceuticals (ACAD) announced that it has entered into an agreement with Biovail Labs (BLS), a wholly owned subsidiary of Valeant Pharmaceuticals International, to conclude the previously established collaboration to develop and commercialize pimavanserin in the U.S. and Canada. Acadia has now reclaimed global rights to the drug. As part of the transaction, Biovail [...] (ACAD) Acadia Pharmaceuticals Gets Pimavanserin Back
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here